We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
In FiercePharma’s top headlines of 2018, you’ll see not only which stories hit a nerve with the most readers—including a few eyebrow-raisers—but several themes that either dominated the news all year
Merck & Co. boasted some major success in the sales department this year, but the company’s commercial organization will still get a makeover for 2019.
The CEO job at Spanish drugmaker Almirall lured Sanofi EVP Peter Guenter away from his role leading the company's diabetes and cardiovascular business.